Clinical characteristics of progressive relapsing multiple sclerosis.

Item

http://www.wikidata.org/entity/Q35870214

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Clinical characteristics of progressive relapsing multiple sclerosis.

@ast

Clinical characteristics of progressive relapsing multiple sclerosis.

@en

type

Item

label

Clinical characteristics of progressive relapsing multiple sclerosis.

@ast

Clinical characteristics of progressive relapsing multiple sclerosis.

@en

prefLabel

Clinical characteristics of progressive relapsing multiple sclerosis.

@ast

Clinical characteristics of progressive relapsing multiple sclerosis.

@en

P1476

Clinical characteristics of progressive relapsing multiple sclerosis.

@en

P2093

F D Lublin

http://www.w3.org/2001/XMLSchema#string

G R Cutter

http://www.w3.org/2001/XMLSchema#string

M J Tullman

http://www.w3.org/2001/XMLSchema#string

R J Oshinsky

http://www.w3.org/2001/XMLSchema#string

P2860

Defining the clinical course of multiple sclerosis: Results of an international survey

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

Multiple sclerosis

Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability.

The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force.

Effect of relapses on development of residual deficit in multiple sclerosis.

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK.

P304

451-454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1191/1352458504MS1059OA

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15327045

http://www.w3.org/2001/XMLSchema#string

P921

progressive relapsing multiple sclerosis